ZA979642B - Heterocyclic compounds, compositions and uses. - Google Patents

Heterocyclic compounds, compositions and uses.

Info

Publication number
ZA979642B
ZA979642B ZA9709642A ZA979642A ZA979642B ZA 979642 B ZA979642 B ZA 979642B ZA 9709642 A ZA9709642 A ZA 9709642A ZA 979642 A ZA979642 A ZA 979642A ZA 979642 B ZA979642 B ZA 979642B
Authority
ZA
South Africa
Prior art keywords
compositions
heterocyclic compounds
heterocyclic
compounds
Prior art date
Application number
ZA9709642A
Inventor
Poul Jacobsen
Svend Treppendahl
Paul Stanley Bury
Anders Kanstrup
Lise Brown Christiansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA979642B publication Critical patent/ZA979642B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9709642A 1996-10-28 1997-10-28 Heterocyclic compounds, compositions and uses. ZA979642B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK120096 1996-10-28

Publications (1)

Publication Number Publication Date
ZA979642B true ZA979642B (en) 1998-04-28

Family

ID=8102107

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9709642A ZA979642B (en) 1996-10-28 1997-10-28 Heterocyclic compounds, compositions and uses.

Country Status (8)

Country Link
EP (1) EP0937058A1 (en)
JP (1) JP2001502705A (en)
AU (1) AU4700097A (en)
CA (1) CA2270113A1 (en)
IL (1) IL129622A0 (en)
NO (1) NO992010L (en)
WO (1) WO1998018773A1 (en)
ZA (1) ZA979642B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000039120A2 (en) * 1998-12-30 2000-07-06 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
WO2006032086A1 (en) * 2004-09-21 2006-03-30 Novogen Research Pty Ltd Chroman derivatives, medicaments and use in therapy
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
JP4913056B2 (en) * 2004-09-21 2012-04-11 マーシャル エドワーズ，インコーポレーテッド Substituted chroman derivatives, pharmaceuticals, and therapeutic uses
WO2006032085A1 (en) * 2004-09-21 2006-03-30 Novogen Research Pty Ltd Substituted chroman derivatives, medicaments and use in therapy
WO2012061413A2 (en) 2010-11-01 2012-05-10 Marshall Edwards, Inc. Isoflavonoid compositions and methods for the treatment of cancer
ES2643407T3 (en) * 2014-02-07 2017-11-22 Novogen Ltd. Functionalized benzopyran compounds and their use
ES2877712T3 (en) 2015-02-02 2021-11-17 Mei Pharma Inc Combination therapies for use in the treatment of breast cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340276A (en) * 1964-04-01 1967-09-05 Ciba Geigy Corp 3, 4-diphenyl-chromans
DE1543749A1 (en) * 1966-02-16 1969-12-11 Merck Ag E Process for the preparation of 3,4-cis-4-aryl-isoflavans
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
HUP9702244A3 (en) * 1995-01-13 1999-12-28 Novo Nordisk As Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders

Also Published As

Publication number Publication date
AU4700097A (en) 1998-05-22
IL129622A0 (en) 2000-02-29
EP0937058A1 (en) 1999-08-25
NO992010D0 (en) 1999-04-27
CA2270113A1 (en) 1998-05-07
NO992010L (en) 1999-06-25
JP2001502705A (en) 2001-02-27
WO1998018773A1 (en) 1998-05-07

Similar Documents

Publication Publication Date Title
HK1018780A1 (en) 6-Phenylpyridine-2-ylamine derivatives, the composition and use thereof.
ZA978178B (en) Composition.
ZA97912B (en) Heterocyclic compounds.
ZA978579B (en) Herbicidal composition.
ZA9811599B (en) Ortho-anthranilamide derivatives as anti-coagulants.
ZA984849B (en) Compositions.
EP0956018A4 (en) Imidazole compounds, compositions and use
ZA9711313B (en) Stilbene compounds containing an adamantyl-group, compositions containing them and uses thereof.
ZA975261B (en) Composition.
GB9712317D0 (en) Composition, compound and use
GB9608485D0 (en) Compositions, processes and uses
GB9608488D0 (en) Compositions, processes and uses
HUP0002861A3 (en) Benzothiophene derivatives, and compositions containing the same
ZA979617B (en) Novel heterocyclic compounds.
ZA9811502B (en) Novel composition.
ZA979642B (en) Heterocyclic compounds, compositions and uses.
ZA979643B (en) Heterocyclic compounds, compositions and uses.
ZA979644B (en) Heterocyclic compounds, compositions and uses.
ZA979898B (en) Organic compositions.
ZA979649B (en) Heterocyclic compounds, compositions and uses.
GB9608489D0 (en) Compositions, processes and uses
ZA200006118B (en) Novel composition.
ZA979646B (en) Heterocyclic compounds, compositions and uses.
GB9706293D0 (en) Compositions, processes and uses
GB9706136D0 (en) Compositions,processes and uses